ask="N/A"
ask_size="N/A"
average_daily_volume="18551"
bid="N/A"
bid_size="N/A"
book_value="0.4420"
change="-0.0688"
change_from_200_day_moving_average="-0.2476"
change_from_50_day_moving_average="-0.8644"
change_from_52_week_high="-2.9688"
change_From_52_week_low="1.8812"
change_in_percent="-1.3624%"
close="4.9812"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.4550"
ebitda="-11.23M"
eps_estimate_current_year="-0.4200"
eps_estimate_next_quarter="-0.1600"
eps_estimate_next_year="-0.5000"
ex_dividend_date="N/A"
float_shares="3301000"
high="5.0500"
high_52_weeks="7.9500"
last_trade_date="2/23/2017"
last_trade_price="4.9812"
last_trade_size="100"
last_trade_time="4:00pm"
low="4.8500"
low_52_weeks="3.1000"
market_capitalization="143.01M"
moving_average_200_day="5.2288"
moving_average_50_day="5.8456"
name="OncoCyte Corporation Common Sto"
notes="N/A"
one_year_target_price="9.6700"
open="5.0500"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-4.7348%"
percent_change_from_50_day_moving_average="-14.7870%"
percent_change_from_52_week_high="-37.3434%"
percent_change_from_52_week_low="+60.6839%"
previous_close="5.0500"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="11.4253"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="28709000"
short_ratio="4.2600"
stock_exchange="ASE"
symbol="OCX"
volume="17350"
weeks_range_52="3.1000 - 7.9500"
